Article
Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival
1 Sept 2022
Abstract excerpt
Clinical studies of cancer patients have shown that overexpression or amplification of thymidylate synthase (TS) correlates with a worse clinical outcome. We previously showed that elevated TS exhibits properties of an oncogene and promotes pancreatic neuroendocrine tumors (PanNETs) with a long latency. To study the causal impact of elevated TS levels in PanNETs, we generated a mouse model with elevated human TS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
